Elevated METTL3 level in cancer cells increases m6A modification in YAP mRNA transcripts which are recognized by m6A readers YTHDF1 and YTHDF3 that are also upregulated in NSCLC cells. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.